Abcellera Biologics Inc

ABCL:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/15/21 EST
45.00quote price arrow up+0.59 (+1.33%)
Volume
1,990
Close
44.41quote price arrow down-2.23 (-4.78%)
Volume
995,129
52 week range
36.27 - 71.91

...

Loading . . .

KEY STATS

  • Open45.51
  • Day High46.55
  • Day Low44.07
  • Prev Close46.64
  • 52 Week High71.91
  • 52 Week High Date12/11/20
  • 52 Week Low36.27
  • 52 Week Low Date01/11/21
  • Market Cap11,793.96M
  • Shares Out265.57M
  • 10 Day Average Volume1.41M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-309.48
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-11.56M
  • ROE (MRQ)-
  • Revenue (MRQ)20.45M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)1.36%
  • Debt To Equity (MRQ)2.53%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Abcellera Biologics Inc News

There is no recent news for this security.

Latest ABCL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AbCellera Biologics Inc. is a biotechnology company, which offers drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. Its platform incorporates and integrates technology tools from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning and data science. The Company is engaged in the business of applying a multiple technology in its medical research and...
Carl Hansen Ph.D.
Chief Executive Officer
Andrew Booth
Chief Financial Officer
Tryn Stimart J.D.
General Counsel
Address
2215 Yukon Street
Vancouver, BC
V5Y 0A1
Canada